The potential of water-soluble polymeric carriers in targeted and site-specific drug delivery

Journal of Controlled Release - Tập 11 - Trang 279-290 - 1990
Jindrich Kopecˇek1
1Center for Controlled Chemical Delivery and Departments of Pharmaceutics and Bioengineering, University of Utah, 421 Wakara Way, Salt Lake City, UT U.S.A.

Tài liệu tham khảo

Kopecˇek, 1982, Biodegradation of polymers for biomedical use, 305 Kopecˇek, 1987, Targetable polymeric prodrugs, J. Controlled Release, 6, 315, 10.1016/0168-3659(87)90085-X Kopecˇek, 1987, Poly[N-(2-hydroxypropyl)methacrylamide macromolecules as drug carrier systems, 152 Lloyd, 1986, Targeting with synthetic polymers: A realistic goal, 97 Helenius, 1983, Endosomes, Trends Biol. Sci., 245, 10.1016/0968-0004(83)90350-X Pastan, 1983, Receptor-mediated endocytosis: coated pits, receptosomes and the Golgi, Trends Biol. Sci., 250, 10.1016/0968-0004(83)90351-1 Kopecˇek, 1984, Controlled biodegradability of polymers — a key to drug delivery systems, Biomaterials, 5, 19, 10.1016/0142-9612(84)90062-0 Rejmanová, 1983, Polymers containing enzymatieally degradable bonds. 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B, Makromol. Chem., 184, 2009, 10.1002/macp.1983.021841006 Sˇubr, 1986 Rejmanová, 1985, Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N- (2-hydroxypropyl)methacrylamide copolymers, Biomaterials, 6, 45, 10.1016/0142-9612(85)90037-7 Duncan, 1983, Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues, Biochim. Biophys. Acta, 755, 518, 10.1016/0304-4165(83)90258-1 Seymour, 1987, Potential of sugar residues attached to N-(2-hydroxypropyl)methacrylamide copolymers as targeting groups for the selective delivery of drugs, J. Bioactive Compat. Polym., 2, 97, 10.1177/088391158700200201 R˛íhová, 1986, Bioaffinity therapy with antibodies and drugs bound to soluble synthetic polymers, J. Chromatogr. Biomed. Appl., 376, 221, 10.1016/S0378-4347(00)80839-7 Rˇihová, 1988, Antibody directed affinity therapy applied to the immune system:In vivo effectiveness and limited toxicity of daunomycin conjugates to HPMA copolymers and targeting antibody, Clin. Immunol. Immonopathol., 46, 100, 10.1016/0090-1229(88)90010-4 Duncan, 1986, Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats, Biochim. Biophys. Acta, 880, 62, 10.1016/0304-4165(86)90120-0 Duncan, 1987, Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 1. Evaluation of daunomycin and puromycin conjugates in vitro, Br. J. Cancer, 55, 165, 10.1038/bjc.1987.33 Duncan, 1988, Anticancer agents coupled to N- (2-hydroxypropyl)methacrylamide copolymers. 2. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia, Br. J. Cancer, 57, 147, 10.1038/bjc.1988.31 Duncan, 1989, Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210in vivo, J. Controlled Release, 10, 51, 10.1016/0168-3659(89)90017-5 L.W. Seymour, K. Ulbrich, J. Strohalm, J. Kopecˇek and R. Duncan, Pharmacokinetics of polymer-bound adriamycin, Biochem. Pharmacol., submitted. Cummings, 1986, Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycone in AKR mice bearing a subcutaneously growing Ridgway osteogenic sarcoma, Eur. J. Cancer, Clin. Oncol., 22, 451, 10.1016/0277-5379(86)90112-4 Maeda, 1988, Improvement of pharmacological properties of protein drugs by tailoring with synthetic polymers, J. Bioactive Compat. Polym., 3, 27, 10.1177/088391158800300104 Busch, 1981, Studies on the metabolism of radioactive albumin in tumor bearing rats, Cancer Res., 21, 371 Cassidy, 1988, Daunomycin-N-(2-hydroxypropyl)methacrylamide copolymers as a drug delivery system in a rat tumor model Cassidy, 1989, Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumor model, Biochem. Pharmacol., 38, 875, 10.1016/0006-2952(89)90274-8 Sehested, 1987, Inuerose in non specific adsorptive endocytosis in anthracycline and vinca alkaloid resistant Ehrlich ascites tumor cell lines, J. Nat. Cancer Inst., 78, 171, 10.1093/jnci/78.1.171 Rˇíhová, 1989, Action of polymeric prodrugs based on N-(2-hydroxypropyl)methacrylamide copolymers. II. Body distribution and T-cell accumulation of free and polymer bound [125I]daunomycin, J. Controlled Release, 10, 37, 10.1016/0168-3659(89)90016-3 Duncan, 1984, Biological evaluation of soluble synthetic polymers as drug carriers, 9 P. Rossmann et al., unpublished results. Rˇíhová, 1989, Biocompatibility of N-(2-hydroxypropyl)methacrylamide copolymers containing adriamycin, Biomaterials, 10, 335 P.A. Flanagan, B.Rˇíhová, V.Sˇubr, J. Kopecˇek and R. Duncan, Immunogenicity of protein — N- (2-hydroxypropyl)methacrylamide copolymer conjugates measured in A/J and B10 mice, Biochim. Biophys. Acta, submitted. P.A. Flanagan et al., unpublished results. Wieder, 1983, Enzyme therapy. II. Effect of covalent attachment of polyethylene glycol on biochemical parameters and immunological determinants of β-glucosidase and β-galactosidase, J. Appl. Biochem., 5, 337 Abuchowski, 1977, alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol, J. Biol. Chem., 252, 3578, 10.1016/S0021-9258(17)40291-2 Abuchowski, 1979, Treatment of LS1787 tumor-bearing BDF mice with a nonimmunogenic L>-glutaminase-L-asparaginase, Cancer Treat. Rep., 63, 1127 Davis, 1981, Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol, Clin. Exp. Immunol., 46, 649 Sehon, 271988, Conversion of xenogenic monoclonal antibodies to specific tolerogens Spikes, 1988, Photosensitization, 79 Bayley, 1987, Photoactivatable drugs, Trends Pharm. Sci., 8, 138, 10.1016/0165-6147(87)90183-0 Krinick, 1988, Targetable photoactivatable drugs. 1. Synthesis of water-soluble galactosamine containing polymeric carriers of chlorin e6 and their photodynamic effect on PLC cells in vitro, 997, 70 K.B. O'Hare, I.C. Hume, L. Scarlett, V. Chytrý, P. Kopecˇková, J. Kopecˇek and R. Duncan, Evaluation of anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. Effect of galactose on interaction with hepatoma cells in culture, Hepatology, in press. Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival; Application of proliferation and cytotoxicity assays, J. Immunol., 65, 55 N.L. Krinick, B.Rˇíhová, K. Ulbrich, J. Strohalm and J. Kopecˇek, Targetable photoactivatable drugs. 2. Biological activity of HPMA copolymer-anti Thy 1.2 antibody-chlorin e6 conjugates, Makromol. Chem., in press. Saffran, 1986, A new approach to the oral administration of insulin and other peptide drugs, Science, 233, 1081, 10.1126/science.3526553 Brown, 1983, A. Polymeric drug for treatment of inflammatory bowel disease, J. Med. Chem., 26, 1300, 10.1021/jm00363a015 Parkinson, 1980 Kumar, 1985, Chelating copolymers containing photosensitive functionalities. 3. Photochromism of crosslinked polymers, Macromolecules, 18, 1525, 10.1021/ma00150a002 Brown, 1981, Reduction of polymeric azo and nitro dyes by intestinal bacteria, Appl. Environ. Microbiol., 41, 1283, 10.1128/AEM.41.5.1283-1286.1981 Cartlidge, 1987, Soluble, crosslinked N-(2-hydroxypropyl) methacrylamide copolymers as potential drug carriers. 2. Effect of molecular weight on blood clearance and body distribution in the rat after intravenous administration. Distribution of unfractionated copolymer after intraperitoneal, subcutaneous or oral administration, J. Controlled Release, 4, 253, 10.1016/0168-3659(87)90017-4 Cartlidge, 1987, Soluble, crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers. 3. Targeting by incorporation of galactosamine residues. Effect of route of administration, J. Controlled Release, 4, 265, 10.1016/0168-3659(87)90018-6 Bridges, 1988, Soluble N-(2-hydroxypropyl)methacrylamide copolymers as a potential oral, controlled release, drug delivery system. 1. Bioadhesion to the rat intestine in vitro, Int. J. Pharm., 44, 213, 10.1016/0378-5173(88)90118-4 Mirelman, 1982, Carbohydrate recognition mechanisms which mediate microbial adherence to mammalian mucosal surfaces, 7, 177 Ashkenazi, 1986, Adherence of non-fimbriate entero-invasive Escherichia coli0/24 to guinea pig intestinal tract in vitro and in vivo, J. Med. Microbiol., 21, 117, 10.1099/00222615-21-2-117 Grim, 1989, Bioadhesive water-soluble polymeric drug carriers for site-specific oral drug delivery. 1. Synthesis, characterization, and 5-aminosalicylic acid release in vitro, 16, 211 Fornu˚sek, 1989, Bioadhesive water-soluble polymeric drug carriers for site-specific oral drug delivery. 2. Fate after oral administration to guinea pigs, 16, 398 Duncan, 1981, Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system, Biochim. Biophys. Acta, 678, 143, 10.1016/0304-4165(81)90058-1